Altai Capital said last month it had "serious concerns about the company’s significant share price underperformance." ...

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.

NEW YORK — Several Delta Dental dental health plan administrators said on Thursday that they will begin coverage of OraLiva's oral cancer test.

The CitoCBC system received FDA 510(k) clearance and CLIA waiver almost a year ago and provides results in about eight minutes in near-patient settings.

Diagnostics is already operating somewhat separately from the firm's other two business units under its new organizational structure, company officials said.

The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

Chairman and CEO Adam Schechter said that deals may open up as hospital systems grow concerned about Medicaid cuts and the end of Affordable Care Act subsidies.

President and CEO Jim Davis said he believes PAMA reform will pass this year but said another temporary delay will likely be needed to postpone cuts slated for February 1.

Sedia's single-use, qualitative immunoassay, called the Asanté HIV-1/2 Oral Fluid Test, detects antibodies to HIV-1 and HIV-2 using oral fluids in as little as 20 minutes and is intended for use by ...

The firm said it has appointed Abhishek Jain, a veteran of CareDx and Agilent Technologies, to be its next chief financial officer.

Last week, readers were most interested in a story about concerns about BillionToOne's Unity NIPT due to false negative results.

NEW YORK — Point-of-care testing firm Truvian Health said on Monday that nine tests that run on its TruVerus benchtop blood analyzer have received 510(k) clearances from the US Food and Drug ...